Autologous stem cell transplantation for the treatment of MGRS (monoclonal gammopathy of renal significance): experience from the University of Calgary

Leuk Lymphoma. 2025 Dec 9:1-3. doi: 10.1080/10428194.2025.2598362. Online ahead of print.

Authors

Daniel Cabello Modesto¹, Sylvia McCulloch², Jason Tay², Victor H Jimenez Zepeda^{2

3}

Affiliations

¹ IS Department of Medical Oncology and Hematology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
² Department of Medical Oncology and Hematology, Arthur JE Child Comprehensive Cancer Centre, Calgary, Alberta, Canada.
³ University of Calgary/Department of Medical Oncology and Hematology, Arnie Charbonneau Cancer Research Institute, Calgary, Alberta, Canada.

PMID: 41368685
DOI: 10.1080/10428194.2025.2598362

No abstract available

Keywords: Monoclonal gammopathy of renal significance; autologous stem cell transplantation; light chain deposition disease.